Samaria Council Chairman Yossi Dagan concluded a four-day series of bipartisan meetings in Washington on Wednesday to secure ...

As biomarker testing and the demand for tumor-agnostic therapies rise, ROZLYTREK can potentially target a specialized yet valuable market segment. While competition from other TRK inhibitors ...